BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1511005)

  • 1. Albumin and fatty acid effects on the stimulated production of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) by human polymorphonuclear leukocytes.
    Wheelan P; Clay KL
    Biochim Biophys Acta; 1992 Aug; 1127(3):284-92. PubMed ID: 1511005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes.
    Sugiura T; Fukuda T; Masuzawa Y; Waku K
    Biochim Biophys Acta; 1990 Dec; 1047(3):223-32. PubMed ID: 2123719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
    Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
    Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The origin of 1H NMR-visible triacylglycerol in human neutrophils. Highfatty acid environments result in preferential sequestration of palmitic acid into plasma membrane triacylglycerol.
    Wright LC; Obbink KL; Delikatny EJ; Santangelo RT; Sorrell TC
    Eur J Biochem; 2000 Jan; 267(1):68-78. PubMed ID: 10601852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin.
    Ludwig JC; Hoppens CL; McManus LM; Mott GE; Pinckard RN
    Arch Biochem Biophys; 1985 Sep; 241(2):337-47. PubMed ID: 4037794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor regulates phospholipid metabolism in human neutrophils.
    Tou JS
    Lipids; 1989 Sep; 24(9):812-7. PubMed ID: 2586238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet-activating factor biosynthesis via the acetyltransferase by arachidonic and oleic acids in ionophore A23187-stimulated bovine neutrophils.
    Remy E; Lenoir G; Houben A; Vandesteene C; Remacle J
    Biochim Biophys Acta; 1989 Sep; 1005(1):87-92. PubMed ID: 2505852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid.
    Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M
    Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1.
    Shikano M; Masuzawa Y; Yazawa K
    J Immunol; 1993 Apr; 150(8 Pt 1):3525-33. PubMed ID: 8468486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of paf-acether. XI. Regulation of acetyltransferase by enzyme-substrate imbalance.
    Ninio E; Joly F; Bessou G
    Biochim Biophys Acta; 1988 Nov; 963(2):288-94. PubMed ID: 3196734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation.
    Ribaldi E; Mezzasoma AM; Francescangeli E; Prosdocimi M; Nenci GG; Goracci G; Gresele P
    Br J Pharmacol; 1996 Jul; 118(6):1351-8. PubMed ID: 8832056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of arachidonic acid on indices of phospholipase A2 activity in the human neutrophil.
    Winkler JD; Sung CM; Hubbard WC; Chilton FH
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):825-31. PubMed ID: 8387780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented production of platelet-activating factor in human polymorphonuclear leukocytes by ketone bodies.
    Sugiura T; Ojima-Uchiyama A; Masuzawa Y; Waku K
    FEBS Lett; 1989 Dec; 258(2):351-4. PubMed ID: 2513232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of free fatty acids on release of superoxide and on change of shape by human neutrophils. Reversibility by albumin.
    Badwey JA; Curnutte JT; Robinson JM; Berde CB; Karnovsky MJ; Karnovsky ML
    J Biol Chem; 1984 Jun; 259(12):7870-7. PubMed ID: 6330088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
    Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA
    J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine.
    Triggiani M; Oriente A; Golino P; Gentile M; Battaglia C; Brevetti G; Marone G
    Biochem Pharmacol; 1999 Oct; 58(8):1341-8. PubMed ID: 10487538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils.
    Doebber TW; Wu MS
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7557-61. PubMed ID: 3478712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
    Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
    J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil.
    Fonteh AN; Winkler JD; Torphy TJ; Heravi J; Undem BJ; Chilton FH
    J Immunol; 1993 Jul; 151(1):339-50. PubMed ID: 8392098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
    Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
    Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.